Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Senegal

HIV Epidemic

  • 5% Estimated HIV prevalence among adults 15–49 Years (2015)
  • 1,800 Estimated AIDS-related deaths among adults 15+ Years (2015)
  • 17,192 Estimated number of adults living with HIV receiving antiretroviral treatment (ART) (2015)

Source: UNAIDS Global Report 2016

TB Epidemic

  • 139/100,000 Estimated TB Incidence (2015)
  • 7% of tested TB patients who were HIV-positive (2015)

Source: WHO Global TB Control Report 2016

What We Do

The U.S. Centers for Disease Control and Prevention (CDC) began working in Senegal in 2001, supporting the HIV/STI sentinel surveillance program. Since 2010, through the President’s Emergency Plan for Aids Relief (PEPFAR), CDC has continued to support Senegal’s Ministry of Health to build a sustainable and reliable national HIV surveillance system by developing a functioning HIV case reporting system, supporting the collection of quality data on key populations, such as female sex workers and men who have sex with men, and in high prevalence areas, strengthening the quality of routine prevention of mother-to-child transmission of HIV data and on site HIV Rapid testing. CDC has also provided support in laboratory capacity building, and the implementation of effective laboratory quality management system, including external quality assurance to address existing challenges and gaps in HIV testing and ensure access to high quality HIV diagnostics, in particular for early infant diagnosis and viral load testing.

Discover more about CDC’s work in Senegal by viewing our detailed country profile.

More Information

More information and data regarding TB in Senegal is available online at WHO's TB Country Profiles.

More information about CDC’s global health work in Senegal is available online at CDC in Senegal.

Top